glp-1 long-term use safety Check Labs for GLP-1 Therapy

In physiciansupervised settings, BPC157 and TB500 have shown favorable safety profiles in preclinical and early clinical use, with most side effects being mild and transient (such as temporary injectionsite irritation or mild digestive changes)

There is no evidence that Ozempic directly causes diverticulitis

Gibson et al., 2004

GLP-1 induced skin ageing is a new phenomenon that is affecting patients in different ways

Serious & unknown risks Not established The Phase 2 trials didn't turn up an unexpected serious safety signal, but they were short

This effect reduces appetite and supports weight loss, making them increasingly popular beyond diabetes treatment